Variables | N (%) |
---|---|
Gender | Â |
 Male | 295 (44.4) |
 Female | 369 (55.6) |
Age | Â |
 <70 | 372 (56.0) |
 ≥70 | 292 (44.0) |
Preoperative renal function | Â |
 eGFR ≥ 60 | 298 (44.9) |
 60 >eGFR ≥15 | 316 (47.6) |
 eGFR <15 | 50 (7.5) |
Side | Â |
 Left | 326 (49.1) |
 Right | 338 (50.9) |
Transplant recipient | Â |
 No | 653 (98.3) |
 Yes | 11 (1.7) |
Ipsilateral hydronephrosis | Â |
 Absence | 290 (43.7) |
 Presence | 374 (56.3) |
Tobacco consumption | Â |
 No | 543 (81.8) |
 Yes | 121 (18.2) |
Surgical approach | Â |
 Open | 445 (67.0) |
 Laparoscopic | 219 (33.0) |
Tumor size | Â |
 ≤3 cm | 373 (56.2) |
 >3 cm | 291 (43.8) |
Architecture | Â |
 Papillary | 515 (77.6) |
 Sessile | 149 (22.4) |
Ureteroscopy | Â |
 No | 583 (87.8) |
 Yes | 81 (12.2) |
Location | Â |
 Pelvis | 368 (55.4) |
 Ureter | 296 (44.6) |
 Upper ureter | 58 (8.7) |
 Middle ureter | 68 (10.2) |
 Lower ureter | 170 (25.6) |
Multifocality | Â |
 No | 505 (76.1) |
 Yes | 159 (23.9) |
CIS | Â |
 Absence | 645 (97.1) |
 Presence | 19 (2.9) |
Contralateral recurrence | Â |
 No | 634 (95.5) |
 Yes | 30 (4.5) |
Bladder recurrence | Â |
 No | 441 (66.4) |
 Yes | 223 (33.6) |
 Before contralateral UTUC | 209 (31.5) |
 Concomitant and after contralateral UTUC | 14 (2.1) |
Tumor stage | Â |
 Ta or T1 | 221 (33.3) |
 T2 | 237 (35.7) |
 T3 | 194 (29.2) |
 T4 | 12 (1.8) |
Tumor grade | Â |
 G1 | 21 (3.2) |
 G2 | 360 (54.2) |
 G3 | 283 (42.6) |
N status | Â |
 N+ | 47 (7.1) |
 cN0 or pN0 | 617 (92.9) |
Adjuvant therapy | Â |
 No | 641 (96.5) |
 Yes | 23 (3.5) |